#top-leaderboard-ads, .stickyads { position: static !important; }

How should dermatologists evaluate whether lebrikizumab is a better option than dupilumab for a given patient?

Name: How should dermatologists evaluate whether lebrikizumab is a better option than dupilumab for a given patient?
Uploaded: 2025-07-01T00:00:00.000Z
Description: How should dermatologists evaluate whether lebrikizumab is a better option than dupilumab for a given patient?

Featuring Pearl Kwong, MD | HCA Florida Orange Park HospitalJacksonville, Florida | Published July 01, 2025

Related CME

Related Media